BIO 2005: A look at this year's show

BIO 2005 is one of the largest gatherings in Philadelphia since the 2000 Republican Convention, and city officials are hoping to showcase their bio-friendly initiatives as they woo expanding companies to the area. In case anyone missed the point, a local group of biotech players commissioned the Milken Institute to compare the area's life sciences industry to other biotech clusters. Milken ranked Philadelphia third in the country, behind Boston and Greater San Francisco. Interestingly, it also ranked Philadelphia well ahead of San Diego (6) and Seattle (10), both regions with a big group of biotech companies beavering away at new drugs.

- read this story from the Philadelphia Inquirer for more 

PLUS: About a third of the 18,000 attendees on hand in Philadelphia arrived from outside the country. The growing foreign presence underscores the dramatic gains that other countries such as South Korea, China and India are making in the industry. Article

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.